Brain-computer interface allows man with ALS to talk in real time
An investigational brain-computer interface has allowed a man diagnosed with amyotrophic lateral sclerosis (ALS) to speak in real…
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
An investigational brain-computer interface has allowed a man diagnosed with amyotrophic lateral sclerosis (ALS) to speak in real…
A bipartisan team of U.S. congressional legislators is calling for increased funding to support research seeking to better understand and…
Treatment with the experimental therapy jacifusen was generally well tolerated and appeared to slow or even reverse disease progression in…
A study found that genetic mutations associated with amyotrophic lateral sclerosis (ALS) lead to problems with the function and…
Adding a low dose of the anti-inflammatory molecule interleukin-2 (IL-2) to treatment with riluzole is safe and may help extend…
Implanting a sensor in a region of the brain that helps to control speech was shown in a U.S. study…
Arizona-based Brad Smith has become the first person with amyotrophic lateral sclerosis (ALS) to receive a brain implant from…
Treatment with regulatory T-cells, or Tregs — a type of anti-inflammatory immune cell — was well tolerated and seemed…
A combination of three drugs — one of them the experimental therapy CuATSM — may be effective for treating…
A rare mutation that leads to abnormally high activity of the CREB3 protein is associated with a reduced risk of…